Evidence map›Paper›PMID 21548012›Full record

ArticlePediatric blood & cancer2011

Sinonasal adenocarcinoma: a rare second malignancy in long term retinoblastoma survivors.

Pooja Bhagia, Agnes Basas Colanta, David H Abramson, Diane L Carlson, Ruth A Kleinerman, Dennis Kraus, Ira J Dunkel

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Pediatric blood & cancer, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 7 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Pooja BhagiaDepartment of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA. bhagiap@mskcc.org
Agnes Basas Colanta
David H Abramson
Diane L Carlson
Ruth A Kleinerman
Dennis Kraus
Ira J Dunkel
Memorial Sloan Kettering Cancer Center · USCleveland Clinic · USDivision of Cancer Epidemiology and Genetics

Funding

Studies of Populations Exposed to Therapeutic Medical Radiation and Other AgentsZIACP010131 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI MORTON, LINDSAY · 2009 to 2025
$81.0M
Intramural NIH HHS ZIA CP010131
6 · The paper itself

Abstract

Retinoblastoma is the most common primary cancer of the eye in children. The incidence of second tumors in survivors of bilateral retinoblastoma and in survivors of unilateral retinoblastoma who presumably carry a germline RB1 mutation is documented. This article describes the previously unrecognized association of sinonasal adenocarcinoma as a second malignancy in retinoblastoma survivors. We present three cases who received radiation therapy as a part of their treatment and developed sinonasal adenocarcinoma as a second malignancy. Sinonasal adenocarcinoma should be considered as a second malignancy in retinoblastoma survivors who present with vague sinus symptoms.

Indexed as

AdenocarcinomaAdultAgedHumansInfant, NewbornMaleMiddle AgedNeoplasms, Radiation-InducedNeoplasms, Second PrimaryNose NeoplasmsParanasal Sinus NeoplasmsRadiotherapyRetinoblastomaSurvivors

Identifiers

PMID21548012
PMCPMC3867788
OpenAlexW2018233936

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.